Translational Development Acquisition (TDAC) EPS (Basic) Growth (1y) (2025 - 2026)
Translational Development Acquisition (TDAC) EPS (Basic) Growth (1y) (2025 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Launch Two Acquisition | 557.86 Mn | 557.86 Mn | - | - |
| 2 | Drugs Made In America Acquisition | 507.00 Mn | 507.00 Mn | - | - |
| 3 | Cantor Equity Partners IV | 467.55 Mn | 467.55 Mn | - | - |
| 4 | GP-Act III Acquisition | 401.06 Mn | 401.06 Mn | - | - |
| 5 | Aldel Financial | 397.49 Mn | 397.49 Mn | - | - |
| 6 | Gores Holdings X | 381.05 Mn | 380.85 Mn | - | -44.78% |
| 7 | Agriculture & Natural Solutions Acquisition | 377.29 Mn | 377.04 Mn | - | - |
| 8 | Blue Water Acquisition Corp. III | 342.12 Mn | 342.08 Mn | - | -110.61% |
| 9 | Berto Acquisition | 313.96 Mn | 313.81 Mn | - | - |
| 10 | Translational Development Acquisition | 182.66 Mn | 182.57 Mn | - | -40.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -75.74% |
| Dec 31, 2025 | -1,080.95% |
| Sep 30, 2025 | 600.80% |